"We specialize in mental health research. Your participation in a voluntary clinical trial is needed and appreciated. With your help, together, we can make a difference! Your participation helps to develop new treatments that improve and advance medical care for future generations. If you're interested in participating in an Alzheimer's Disease, Schizophrenia, Bipolar or Borderline Personality Disorder research trial call us today."

During the past decade, Arch Clinical Trials, LLC conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 9 clinical trials were completed, i.e. on average, 47.4% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 8 clinical trials were completed. i.e. 72.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arch Clinical Trials, LLC" #1 sponsor was "Otsuka Pharmaceutical Development & Commercialization, Inc." with 4 trials, followed by "Karuna Therapeutics" with 3 trials sponsored, "Sunovion" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Allergan" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arch Clinical Trials, LLC" #1 collaborator was "H. Lundbeck A/S" with 2 trials as a collaborator, "Cognitive Research Corporation" with 1 trials as a collaborator and "Syneos Health" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Arch Clinical Trials, LLC" are "Schizophrenia" (12 trials), "Bipolar I Disorder" (2 trials), "Depressive Disorder, Major" (2 trials), "Acute Mania" (1 trials) and "Alzheimer Disease" (1 trials). Many other conditions were trialed in "Arch Clinical Trials, LLC" in a lesser frequency.

Most popular intervention types in "Arch Clinical Trials, LLC" are "Drug" (19 trials), "Biological" (1 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Brexpiprazole" (3 trials), "Xanomeline and Trospium Chloride Capsules" (3 trials), "SEP-363856 75mg" (2 trials) and "ASP4345" (1 trials). Other intervention names were less common.

The vast majority of trials in "Arch Clinical Trials, LLC" are 19 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Arch Clinical Trials, LLC". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Arch Clinical Trials, LLC, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Arch Clinical Trials, LLC, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".